9 Results

People

  1. Lahoud
    Lahoud
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Chung
    Chung
  5. Shah
    Shah
  6. Hassoun
    Hassoun
  7. Korde
    Korde
  8. Lesokhin
    Lesokhin
  9. Mailankody
    Mailankody
  10. Scordo
    Scordo

Groups

  1. Department of Medicine (9)
  2. Hematologic Malignancies, Division of (9)
  3. Bone Marrow Transplant (8)
  4. Center for Hematologic Malignancies (8)
  5. Survivorship Research (8)
  6. Epidemiology and Biostatistics (7)
  7. Biostatistics Service (6)
  8. CTCR Scholars (6)
  9. Hematologic Malignancies Research (5)
  10. Myeloma (5)
  1. "article"
  2. "Oscar Lahoud"
Formats
  1. Journal Article (9)
Groups
  1. Department of Medicine (9)
  2. Hematologic Malignancies, Division of (9)
  3. Bone Marrow Transplant (8)
  4. Center for Hematologic Malignancies (8)
  5. Survivorship Research (8)
  6. Epidemiology and Biostatistics (7)

More Groups

People
  1. Oscar Lahoud (9)
  2. Heather Landau (7)
  3. Sergio Giralt (7)
  4. David Chung (6)
  5. Gunjan Shah (6)
  6. Alexander Lesokhin (5)

More People

Years
  1. 2023 (4)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
Publications
  1. British Journal of Haematology (2)
  2. Leukemia and Lymphoma (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Blood Cancer Journal (1)
  5. JAMA Oncology (1)
  6. Nature Communications (1)

More Publications

Publishers
  1. John Wiley & Sons (2)
  2. Nature Publishing Group (2)
  3. Taylor & Francis Group (2)
  4. American Medical Association (1)
  5. Elsevier Inc. (1)
  6. Elsevier Science, Inc. (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation
    Journal Article

    Elias, S.; Brown, S.; Devlin, S. M.; Barker, J. N.; Cho, C.; Chung, D. J.; Dahi, P. B.; Giralt, S.; Gyurkocza, B.; Jakubowski, A. A.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial
    Journal Article

    Kubicki, T.; Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Robak, P.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Szczepaniak, T.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Journal Article

    Tan, C. R.; Derkach, A.; Nemirovsky, D.; Ciardiello, A.; Diamond, B.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Maclachlan, K.; more...
    Blood Cancer Journal (2023)

    Fulltext@MSK | Save
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Effect of conditioning regimen dose reduction in obese patients undergoing autologous hematopoietic cell transplantation
    Journal Article

    Brunstein, C. G.; Pasquini, M. C.; Kim, S.; Fei, M.; Adekola, K.; Ahmed, I.; Aljurf, M.; Agrawal, V.; Auletta, J. J.; Battiwalla, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save